Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: Bcl-2 prevents the loss of antioxidant enzyme activity

Research output: Contribution to journalArticle

50 Scopus citations

Abstract

When the WEHI7.2 mouse lymphoid cell line was treated with dexamethasone to induce apoptosis the activities and transcript levels of the antioxidant defence enzymes catalase, superoxide dismutase (SOD) and DT-diaphorase exhibited a progressive decrease over 48 hours. Catalase activity was maintained and total SOD and DT-diaphorase activity showed smaller decreases following dexamethasone treatment of WEHI7.2 cells transfected with the bcl-2 oncogene, which protects the cells against apoptosis. Treatment of wild-type WEHI7.2 and bcl-2 transfected cells with a catalase inhibitor, aminotriazole, was not sufficient to induce apoptosis. Antioxidants, including bovine liver catalase, bovine erythrocyte CuZn-SOD, sodium selenite and Trolox, a water soluble vitamin E analogue, as well as hypoxia, inhibited dexamethasone-induced apoptosis. These results suggest that oxidant stress due to the decreased activity of antioxidant defence enzymes may play a role in dexamethasone mediated lymphoid cell apoptosis and that bcl-2 may prevent apoptosis by maintaining the level of critical antioxidant defence mechanisms, which include catalase.

Original languageEnglish (US)
Pages (from-to)207-213
Number of pages7
JournalCell Death and Differentiation
Volume3
Issue number2
StatePublished - Jun 13 1996

Keywords

  • Antioxidant enzymes
  • Apoptosis
  • Lymphocytes
  • Oxidative stress
  • bcl-2

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'Decreased antioxidant defence and increased oxidant stress during dexamethasone-induced apoptosis: Bcl-2 prevents the loss of antioxidant enzyme activity'. Together they form a unique fingerprint.

  • Cite this